Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
19.93
-0.14 (-0.70%)
At close: Aug 13, 2026, 4:00 PM EDT
20.00
+0.07 (0.35%)
Pre-market: Aug 14, 2026, 5:20 AM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $4.37 billion as of August 14, 2026. Its market cap has increased by 656.17% in one year.
Market Cap
4.37B
Enterprise Value
3.49B
1-Year Change
656.17%
Ranking
Category
Stock Price
$19.93
ChartMarket Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has increased from $3.03B to $4.37B, an increase of 43.91%. That is a compound annual growth rate of 6.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 4.37B | 197.86% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ACADIA Pharmaceuticals | 4.99B |
| Dyne Therapeutics | 4.89B |
| Edgewise Therapeutics | 4.70B |
| Parabilis Medicines | 4.64B |
| Veradermics | 4.64B |
| Celcuity | 4.40B |
| Tango Therapeutics | 4.33B |
| Enliven Therapeutics | 4.26B |